tau 284 has been researched along with piperidines in 45 studies
| Studies (tau 284) | Trials (tau 284) | Recent Studies (post-2010) (tau 284) | Studies (piperidines) | Trials (piperidines) | Recent Studies (post-2010) (piperidines) |
|---|---|---|---|---|---|
| 52 | 18 | 21 | 40,235 | 5,221 | 14,545 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (13.33) | 18.2507 |
| 2000's | 12 (26.67) | 29.6817 |
| 2010's | 22 (48.89) | 24.3611 |
| 2020's | 5 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Kikuchi, M; Murata, T; Narita, H; Saito, N; Sakai, A; Tsuzurahara, K; Yato, N | 1 |
| Kikkawa, S; Kikuchi, M; Narita, H; Saito, N; Sakai, A; Yato, N | 1 |
| Matsumoto, Y; Murata, T; Naito, K; Suzuki, T; Takata, I; Tsuzurahara, K | 1 |
| Aga, Y; Endo, T; Kato, M; Kita, J; Kudo, Y; Narita, H; Nishida, A | 1 |
| Ikezawa, K; Kaminuma, O; Kikkawa, H; Kikuchi, M; Naito, K; Ogawa, K | 1 |
| Inagaki, N; Koda, A; Nagai, H; Ueno, M | 1 |
| Iizuka, H; Ishida-Yamamoto, A; Takahashi, H | 1 |
| Fukuda, H; Kamikozawa, Y; Ohashi, R; Sugiura, M; Tamai, I; Yabuuchi, H | 1 |
| Andoh, T; Kuraishi, Y | 1 |
| Lamb, BT; Ryman, D | 1 |
| Ikeda, T; Kureyama, N; Moriyasu, S; Okamura, K; Yamamoto, K; Yamatodani, A | 1 |
| Kambe, N; Matsuda, H; Miyachi, Y; Nakamura, Y; Tanaka, A; Tanizaki, H | 1 |
| Duan, X; Funaki, Y; Ishikawa, Y; Itoh, M; Iwata, R; Kato, M; Miyake, M; Tashiro, M; Watanuki, S; Yanai, K | 1 |
| Fukui, H; Izumi, N; Mizuguchi, H; Ogino, S; Umehara, H | 1 |
| Kabashima, K; Kobayashi, M; Nakamura, M; Tokura, Y | 1 |
| Fujita, T; Gotoh, M; Hashiguchi, K; Okubo, K; Suematsu, K; Tang, H | 1 |
| Ikezawa, Z; Inomata, N; Tatewaki, S | 1 |
| Abelson, MB; Gomes, PJ; Gow, JA; McNamara, TR; Torkildsen, GL; Williams, JI | 2 |
| Atsumi, I; Fujii, A; Iemura, M; Kida, T; Sakai, O; Sakaki, H; Wada, T | 1 |
| Abelson, MB; Bergmann, MT; Gomes, PJ; Gow, JA; Macejko, TT; McNamara, TR; Williams, JI | 1 |
| Lyseng-Williamson, KA | 1 |
| Gow, JA; Klier, SM; McCue, SL; McNamara, TR; Salapatek, AM; Williams, JI | 1 |
| Funaki, Y; Kato, M; Okamura, N; Shibuya, K; Tashiro, M; Yanai, K; Yoshikawa, T; Zhang, D | 1 |
| Abelson, MB; Gomes, PJ; Gow, JA; Kennedy, KS; McNamara, TR; Torkildsen, GL; Williams, JI | 1 |
| Doi, R; Haga, T; Kawakami, T; Kimura, S; Kyoya, M; Nakagawa, K; Soma, Y | 1 |
| Fukuoka, M; Ikoma, A; Kabashima, K; Miyachi, Y; Tanizaki, H | 1 |
| Cho, KH; Choi, HG | 1 |
| Choi, YK; Chung, YH; Jeong, JH; Kang, DY; Kim, H; Kim, HR; Lee, SE; Lee, YS; Nam, YS | 1 |
| Kim, KA; Park, JY | 1 |
| Bielory, L; Duttachoudhury, S; McMunn, A | 1 |
| Hu, X; Liu, J; Shentu, J; Wu, G; Wu, L; Zhai, Y; Zheng, Y; Zhou, H; Zhu, M | 1 |
| Hyeon, JH; Kim, HS; Kim, JY; Kim, YJ; Kwack, SJ; Kwak, HM; Lee, BM; Lee, JD; Lim, DS; Lim, SK; Um, YM; Youn, YS | 1 |
| Anusha, S; Babu Rajeev, CP; Bender, A; Chandramohanadas, R; Chu, TT; Fuchs, JE; Mathai, J; Preiser, PR; Rangappa, KS; Shivananju, N; Sinha, A; Ximei, H | 1 |
| Ichimura, M; Izaki, H; Koyama, T; Okubo, K; Susuta, Y | 1 |
| Kanamitsu, K; Kusuhara, H; Nagaya, Y; Nozaki, Y; Sugiyama, Y | 1 |
| Carrillo-Martin, I; Dimov, V; Gonzalez-Estrada, A | 1 |
| Babu, M; Dudeja, I; Dudeja, L; Janakiraman, A; Sane, K | 1 |
| Han, C; Sun, L; Yu, J; Zhang, C; Zou, Q | 1 |
| Fordjuor, G; Kim, SI; Lee, JE; Lee, JH; Lee, JS; Park, CY | 1 |
| Bharatam, PV; Chakraborti, AK; Giri, S; Sahu, A; Singh, DK; Singh, S; Wani, AA | 1 |
| Cho, SH; Hong, SN; Jeong, JH; Kim, CH; Kim, DW; Kim, DY; Kim, HY; Kim, ST; Kim, SW; Kim, TH; Lee, KH; Mo, JH; Rhee, CS | 1 |
| Ayyappanavar, S; Gangasagara, SB; Jayanthi, CR; Kumar, K; Mittal, P; Preethi, B; Rathod, BLS; Sridhar, S | 1 |
| Huang, J; Li, F; Shao, L; Shi, G; Wang, X; Wu, K; Yan, J; Yang, L; Yin, X | 1 |
5 review(s) available for tau 284 and piperidines
| Article | Year |
|---|---|
Genetic and environmental modifiers of Alzheimer's disease phenotypes in the mouse.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Disease Models, Animal; Environment; Humans; Mice; Mice, Transgenic; Phenotype; Phosphorylation; Piperidines; Pyridines; tau Proteins | 2006 |
Bepotastine (bepreve)--an ophthalmic H1-antihistamine.
Topics: Administration, Topical; Animals; Eye Diseases; Histamine H1 Antagonists; Humans; Ophthalmic Solutions; Piperidines; Pyridines; Randomized Controlled Trials as Topic | 2010 |
Oral bepotastine: in allergic disorders.
Topics: Administration, Oral; Anti-Allergic Agents; Histamine H1 Antagonists; Humans; Hypersensitivity; Piperidines; Pruritus; Pyridines; Rhinitis, Allergic, Perennial; Urticaria | 2010 |
Non-clinical pharmacology, pharmacokinetics, and safety findings for the antihistamine bepotastine besilate.
Topics: Animals; Anti-Allergic Agents; Conjunctivitis, Allergic; Disease Models, Animal; Drug Evaluation, Preclinical; Histamine Antagonists; Humans; Mice; Piperidines; Pruritus; Pyridines; Rats | 2010 |
Bepotastine besilate for the treatment of pruritus.
Topics: Administration, Cutaneous; Administration, Oral; Animals; Clinical Trials as Topic; Conjunctivitis, Allergic; Histamine H1 Antagonists; Humans; Piperidines; Pruritus; Pyridines; Rhinitis, Allergic; Rhinitis, Allergic, Perennial; Urticaria | 2013 |
15 trial(s) available for tau 284 and piperidines
| Article | Year |
|---|---|
Effects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performance.
Topics: Adult; Cetirizine; Cross-Over Studies; Dermatitis, Atopic; Dibenzoxepins; Double-Blind Method; Female; Histamine; Histamine H1 Antagonists; Humans; Iontophoresis; Male; Olopatadine Hydrochloride; Piperidines; Psychomotor Performance; Pyridines; Sleep Stages; Terfenadine | 2004 |
Brain histamine H1 receptor occupancy of orally administered antihistamines, bepotastine and diphenhydramine, measured by PET with 11C-doxepin.
Topics: Administration, Oral; Adult; Brain; Carbon Radioisotopes; Diphenhydramine; Doxepin; Histamine H1 Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Male; Piperidines; Positron-Emission Tomography; Pyridines; Receptors, Histamine H1; Sleep Stages | 2008 |
Bepotastine besilate OD tablets suppress nasal symptoms caused by Japanese cedar pollen exposure in an artificial exposure chamber (OHIO Chamber).
Topics: Administration, Oral; Air Pollutants; Allergens; Anti-Allergic Agents; Atmosphere Exposure Chambers; Cognition; Female; Humans; Male; Nasal Lavage Fluid; Nasal Mucosa; Piperidines; Pollen; Pyridines; Rhinitis, Allergic, Seasonal; Single-Blind Method; Tablets | 2009 |
Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen cha
Topics: Administration, Topical; Adolescent; Adult; Aged; Allergens; Anti-Allergic Agents; Child; Conjunctivitis, Allergic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Ophthalmic Solutions; Piperidines; Prospective Studies; Pruritus; Pyridines; Severity of Illness Index; Time Factors; Treatment Outcome; Young Adult | 2009 |
Multicenter clinical evaluation of bepotastine besilate ophthalmic solutions 1.0% and 1.5% to treat allergic conjunctivitis.
Topics: Adolescent; Adult; Anti-Allergic Agents; Child; Conjunctiva; Conjunctivitis, Allergic; Double-Blind Method; Female; Humans; Hyperemia; Male; Middle Aged; Ophthalmic Solutions; Piperidines; Prospective Studies; Pyridines; Treatment Outcome; Visual Acuity | 2010 |
Bepotastine besilate ophthalmic solution for the relief of nonocular symptoms provoked by conjunctival allergen challenge.
Topics: Adult; Allergens; Conjunctivitis, Allergic; Double-Blind Method; Female; Histamine Antagonists; Humans; Immunization; Male; Middle Aged; Nasal Obstruction; Ophthalmic Solutions; Piperidines; Pyridines | 2010 |
Next-day residual sedative effect after nighttime administration of an over-the-counter antihistamine sleep aid, diphenhydramine, measured by positron emission tomography.
Topics: Administration, Oral; Brain; Cross-Over Studies; Diphenhydramine; Double-Blind Method; Histamine H1 Antagonists; Humans; Hypnotics and Sedatives; Male; Nonprescription Drugs; Piperidines; Positron-Emission Tomography; Pyridines; Receptors, Histamine H1; Sleep Initiation and Maintenance Disorders; Young Adult | 2010 |
Prolonged effectiveness of bepotastine besilate ophthalmic solution for the treatment of ocular symptoms of allergic conjunctivitis.
Topics: Adolescent; Adult; Aged; Anti-Allergic Agents; Child; Conjunctiva; Conjunctivitis, Allergic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hyperemia; Male; Middle Aged; Ophthalmic Solutions; Piperidines; Prospective Studies; Pruritus; Pyridines; Time Factors; Young Adult | 2011 |
UPLC-MS/MS method for determination of bepotastine in human plasma.
Topics: Administration, Oral; Chromatography, Liquid; Drug Stability; Humans; Male; Piperidines; Pyridines; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2014 |
Pharmacokinetic comparisons of bepotastine besilate and bepotastine salicylate in healthy subjects.
Topics: Adult; Area Under Curve; Cross-Over Studies; Healthy Volunteers; Humans; Male; Middle Aged; Piperidines; Pyridines; Salicylates; Single-Blind Method; Young Adult | 2013 |
Comparative fasting bioavailability of 2 bepotastine formulations in healthy male Chinese volunteers: an open-label, randomized, single-dose, 2-way crossover study.
Topics: Adult; Area Under Curve; Asian People; Biological Availability; Chemistry, Pharmaceutical; China; Cross-Over Studies; Drugs, Generic; Fasting; Healthy Volunteers; Humans; Male; Piperidines; Pyridines; Tablets; Tandem Mass Spectrometry; Therapeutic Equivalency; United States; Young Adult | 2014 |
Double-blind placebo-controlled study of bepotastine besilate in pediatric patients with perennial allergic rhinitis.
Topics: Adolescent; Child; Double-Blind Method; Histamine Antagonists; Humans; Piperidines; Pyridines; Rhinitis, Allergic, Perennial | 2015 |
Observer-masked trial comparing efficacy of topical olopatadine (0.1%), bepotastine (1.5%), and alcaftadine (0.25%) in mild to moderate allergic conjunctivitis.
Topics: Adolescent; Adult; Anti-Allergic Agents; Benzazepines; Child; Conjunctiva; Conjunctivitis, Allergic; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Histamine H1 Antagonists; Humans; Imidazoles; Male; Olopatadine Hydrochloride; Ophthalmic Solutions; Piperidines; Prospective Studies; Pyridines; Single-Blind Method; Treatment Outcome; Young Adult | 2019 |
Double-Blind Placebo-Controlled Trial of Bepotastine Salicylate in Patients With Allergic Rhinitis.
Topics: Administration, Oral; Adult; Aged; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Humans; Male; Middle Aged; Piperidines; Pyridines; Rhinitis, Allergic; Salicylates; Sino-Nasal Outcome Test; Treatment Outcome; Young Adult | 2021 |
Comparative analysis of safety and efficacy of Alcaftadine 0.25%, Olopatadine hydrochloride 0.2% and Bepotastine besilate 1.5% in allergic conjunctivitis.
Topics: Anti-Allergic Agents; Benzazepines; Conjunctivitis, Allergic; Double-Blind Method; Humans; Imidazoles; Olopatadine Hydrochloride; Ophthalmic Solutions; Piperidines; Prospective Studies; Pyridines; Treatment Outcome | 2021 |
25 other study(ies) available for tau 284 and piperidines
| Article | Year |
|---|---|
[Anti-allergic activity of betotastine besilate (TAU-284), a new anti-allergic drug].
Topics: Administration, Oral; Animals; Anti-Allergic Agents; Arachidonic Acids; Capillary Permeability; Cells, Cultured; Depression, Chemical; Dose-Response Relationship, Drug; Histamine Antagonists; Histamine Release; Male; Mast Cells; Passive Cutaneous Anaphylaxis; Piperidines; Pyridines; Rats; Rats, Sprague-Dawley | 1997 |
Inhibitory effect of betotastine besilate on antigen-induced airway eosinophil infiltration and peripheral blood eosinophilia in mice.
Topics: Animals; Anti-Allergic Agents; Blood Cell Count; Bronchoalveolar Lavage Fluid; Eosinophilia; Eosinophils; Leukocyte Count; Lung; Male; Mice; Ovalbumin; Piperidines; Pyridines; Respiratory Hypersensitivity | 1997 |
[Effect of betotastine besilate (TAU-284), a novel anti-allergic agent, on experimental allergic rhinitis].
Topics: Airway Resistance; Animals; Anti-Allergic Agents; Capillary Permeability; Disease Models, Animal; Guinea Pigs; Humans; Infant; Male; Piperidines; Pyridines; Rats; Rats, Sprague-Dawley; Rhinitis, Allergic, Perennial | 1997 |
Pharmacokinetic and pharmacodynamic evaluation of central effect of the novel antiallergic agent betotastine besilate.
Topics: Animals; Anti-Allergic Agents; Arousal; Cats; Central Nervous System; CHO Cells; Chromatography, High Pressure Liquid; Cricetinae; Female; Guinea Pigs; In Vitro Techniques; Male; Mice; Motor Activity; Piperidines; Pyridines; Rats; Rats, Wistar; Receptors, Drug; Sleep | 1997 |
A novel anti-allergic drug, betotastine besilate, suppresses interleukin-5 production by human peripheral blood mononuclear cells.
Topics: Adult; Anti-Allergic Agents; Cell Division; Cells, Cultured; Humans; Indicators and Reagents; Interleukin-5; Ketotifen; Male; Middle Aged; Monocytes; Piperidines; Pyridines | 1998 |
Antiallergic action of betotastine besilate (TAU-284) in animal models: A comparison with ketotifen.
Topics: Animals; Anti-Allergic Agents; Asthma; Bronchoconstriction; Disease Models, Animal; Eosinophilia; Eosinophils; Female; Guinea Pigs; Histamine H1 Antagonists; Hypersensitivity; Ketotifen; Male; Passive Cutaneous Anaphylaxis; Piperidines; Platelet Activating Factor; Pyridines; Rats; Rats, Wistar | 1998 |
Effect of P-glycoprotein on intestinal absorption and brain penetration of antiallergic agent bepotastine besilate.
Topics: Adenosine Triphosphatases; Animals; Anti-Allergic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Autoradiography; Biological Transport, Active; Brain; Chromatography, Liquid; Intestinal Absorption; Kinetics; LLC-PK1 Cells; Male; Mass Spectrometry; Mice; Mice, Knockout; Piperidines; Pyridines; Rats; Rats, Sprague-Dawley; Stimulation, Chemical; Swine; Terfenadine; Verapamil | 2006 |
Suppression by bepotastine besilate of substance P-induced itch-associated responses through the inhibition of the leukotriene B4 action in mice.
Topics: Administration, Oral; Animals; Behavior, Animal; Calcium; Dose-Response Relationship, Drug; Ganglia, Spinal; Histamine H1 Antagonists; Leukotriene B4; Male; Mice; Mice, Inbred ICR; Neurons; Neutrophils; Piperidines; Pruritus; Pyridines; Skin; Substance P | 2006 |
Involvement of histamine released from mast cells in acute radiation dermatitis in mice.
Topics: Acute Disease; Animals; Chlorpheniramine; Dose-Response Relationship, Drug; Edema; Erythema; Hair Removal; Histamine; Histamine H1 Antagonists; Histamine Release; Male; Mast Cells; Mice; Mice, Inbred C57BL; Piperidines; Pyridines; Radiodermatitis; Receptors, Histamine H1 | 2007 |
Oral administration of bepotastine besilate suppressed scratching behavior of atopic dermatitis model NC/Nga mice.
Topics: Administration, Oral; Animals; Antipruritics; Behavior, Animal; Dermatitis, Atopic; Disease Models, Animal; Male; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; p-Methoxy-N-methylphenethylamine; Piperidines; Pruritus; Pyridines | 2008 |
Analysis of disease-dependent sedative profiles of H(1)-antihistamines by large-scale surveillance using the visual analog scale.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Asthma; Butyrophenones; Cetirizine; Child; Chlorpheniramine; Dermatitis, Atopic; Dibenzazepines; Dibenzoxepins; Female; Histamine H1 Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Imidazoles; Japan; Male; Middle Aged; Olopatadine Hydrochloride; Pain Measurement; Piperidines; Population Surveillance; Psychomotor Performance; Pyridines; Quality of Life; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Sleep Stages; Surveys and Questionnaires; Terfenadine; Urticaria | 2008 |
Downmodulatory effects of the antihistaminic drug bepotastine on cytokine/chemokine production and CD54 expression in human keratinocytes.
Topics: Cells, Cultured; Chemokine CCL17; Chemokine CXCL10; Chemokines; Cytokines; Dose-Response Relationship, Drug; Down-Regulation; Histamine H1 Antagonists, Non-Sedating; Humans; Intercellular Adhesion Molecule-1; Interleukin-1alpha; Keratinocytes; Piperidines; Pyridines | 2009 |
Multiple H1-antihistamine-induced urticaria.
Topics: Administration, Oral; Adult; Drug Eruptions; Female; Histamine; Histamine H1 Antagonists; Humans; Immunologic Tests; Leukotriene B4; Loratadine; Piperidines; Pyridines; Skin Tests; Terfenadine; Urticaria | 2009 |
Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models.
Topics: Animals; Capillary Permeability; Cells, Cultured; Chemotaxis, Leukocyte; Conjunctiva; Conjunctivitis, Allergic; Disease Models, Animal; Dose-Response Relationship, Drug; Eosinophils; Guinea Pigs; Histamine; Histamine H1 Antagonists; Histamine Release; Leukotriene B4; Male; Mast Cells; Ovalbumin; Peritoneal Cavity; Piperidines; Platelet Activating Factor; Pyridines; Rats; Rats, Wistar | 2010 |
Health-related quality of life assessed by the effect of bepotastine besilate in patients with pruritus: importance of emotions score in atopic dermatitis.
Topics: Adolescent; Adult; Aged; Dermatitis, Atopic; Emotions; Female; Histamine H1 Antagonists; Humans; Male; Middle Aged; Piperidines; Pruritus; Pyridines; Quality of Life; Surveys and Questionnaires; Young Adult | 2012 |
Effects of bepotastine and fexofenadine on histamine-induced flare, wheal and itch.
Topics: Adult; Female; Histamine; Histamine H1 Antagonists, Non-Sedating; Humans; Male; Piperidines; Pruritus; Pyridines; Skin; Terfenadine; Urticaria | 2012 |
Development of novel bepotastine salicylate salt bioequivalent to the commercial bepotastine besilate in beagle dogs.
Topics: Animals; Cross-Over Studies; Dogs; Drug Discovery; Male; Piperidines; Pyridines; Salicylic Acid; Therapeutic Equivalency | 2013 |
Comparative efficacy and bioequivalence of novel h1-antihistamine bepotastine salts (nicotinate and salicylate).
Topics: Animals; Chemical Phenomena; Chromatography, Liquid; Dogs; Female; Guinea Pigs; Histamine Antagonists; Hydrogen-Ion Concentration; Male; Niacin; Piperidines; Pyridines; Rats; Rats, Sprague-Dawley; Salicylates; Tablets; Tandem Mass Spectrometry; Therapeutic Equivalency | 2014 |
Synthesis, characterization and in vitro evaluation of novel enantiomerically-pure sulphonamide antimalarials.
Topics: Acyltransferases; Antimalarials; Humans; Malaria, Falciparum; Models, Molecular; Piperidines; Plasmodium falciparum; Pyridines; Sulfonamides | 2015 |
Quantitative prediction of histamine H1 receptor occupancy by the sedative and non-sedative antagonists in the human central nervous system based on systemic exposure and preclinical data.
Topics: Animals; Brain; Central Nervous System; Diphenhydramine; Histamine H1 Antagonists; Humans; Ketotifen; Macaca fascicularis; Male; Mice; Mice, Inbred Strains; Olopatadine Hydrochloride; Piperidines; Positron-Emission Tomography; Pyridines; Receptors, Histamine H1; Time Factors | 2017 |
Bepotastine besilate for the treatment of perennial allergic rhinitis.
Topics: Humans; Piperidines; Pyridines; Rhinitis, Allergic, Perennial | 2018 |
Identification, Characterization and HPLC Quantification of Process-Related Impurities in Bepotastine Besilate Bulk Drug.
Topics: Anti-Allergic Agents; Chromatography, High Pressure Liquid; Drug Compounding; Drug Contamination; Limit of Detection; Magnetic Resonance Spectroscopy; Piperidines; Pyridines; Tandem Mass Spectrometry | 2020 |
Comparison of cytotoxicities and anti-allergic effects of topical ocular dual-action anti-allergic agents.
Topics: Anti-Allergic Agents; Benzazepines; Cell Survival; Cells, Cultured; Conjunctiva; Cornea; Epithelial Cells; Humans; Imidazoles; Olopatadine Hydrochloride; Piperidines; Pyridines | 2019 |
Characterization of Photodegradation Products of Bepotastine Besilate and In Silico Evaluation of Their Physicochemical, Absorption, Distribution, Metabolism, Excretion and Toxicity Properties.
Topics: Computer Simulation; Conjunctivitis, Allergic; Gas Chromatography-Mass Spectrometry; Humans; Photolysis; Piperidines; Pyridines | 2020 |
Efficient synthesis of bepotastine and cloperastine intermediates using engineered alcohol dehydrogenase with a hydrophobic pocket.
Topics: Alcohol Dehydrogenase; Biocatalysis; Hydrophobic and Hydrophilic Interactions; Kinetics; Piperidines; Pyridines; Stereoisomerism | 2021 |